Francois Martelet - Avax Techs President CEO, Director

AVXT Stock  USD 0.0001  0.00  0.00%   

CEO

Dr. Francois R. Martelet is President, Director of AVAX Technologies, Inc. He was Chief Executive Officer of the Company. He was elected to the board of Directors of AVAX Technologies, Inc. Dr. Martelet is a senior pharmaceutical executive and brings to AVAX over 16 years of international experience. Most recently, he served as VicePresident and Global Franchise Head, Oncology with Merck Co. Prior to that, Dr. Martelet was the Regional Pharmaceutical Head, Central Eastern Europe, Middle East and Africa for Novartis Pharma AG, in addition served in various senior officer positions within units of Novartis Pharmaceuticals, including leading the Oncology Business Units in Asia, Latin America, Central and Eastern Europe, the Middle East and Africa. Prior to joining Novartis, Dr. Martelet served in various oncologyrelated capacities with ScheringPlough International, Eli Lilly Corporation and F. Hoffmanla Roche, AG. Dr. Martelet is presently providing consulting services for MedNest LLC, The Gerson Lerhman Group LLC, and Greenwood Research LLC, which provide business development and operational consulting services to medical technology, pharmaceutical, biotechnology and health care service providers since 2015.
Age 51
Tenure 9 years
Address 2000 Hamilton Street, Philadelphia, PA, United States, 19130
Phone215-241-9760
Webhttps://www.avax-tech.com
Martelet received a Doctorate in Medicine with distinction and a Pharmaceutical Marketing Master Degree in Business from Dijon University, France. He also holds a degree in Legal Medicine from R. Descartes University School of Medicine, Paris.

Avax Techs Management Efficiency

The company has return on total asset (ROA) of (4.5732) % which means that it has lost $4.5732 on every $100 spent on assets. This is way below average. Avax Techs' management efficiency ratios could be used to measure how well Avax Techs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 2.09 in 2024, whereas Return On Tangible Assets are likely to drop (1.08) in 2024. Total Current Liabilities is likely to gain to about 25.4 M in 2024, despite the fact that Change To Liabilities is likely to grow to (93.7 K).
The company currently holds 3.33 M in liabilities. Avax Techs has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Avax Techs until it has trouble settling it off, either with new capital or with free cash flow. So, Avax Techs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avax Techs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avax to invest in growth at high rates of return. When we think about Avax Techs' use of debt, we should always consider it together with cash and equity.
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania. Avax Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 9 people. Avax Techs (AVXT) is traded on OTCCE Exchange in USA and employs 9 people. Avax Techs is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Avax Techs Leadership Team

Elected by the shareholders, the Avax Techs' board of directors comprises two types of representatives: Avax Techs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avax. The board's role is to monitor Avax Techs' management team and ensure that shareholders' interests are well served. Avax Techs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avax Techs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Adele Sommerfeld, CEO
Carl Spana, Director
Richard Rainey, Principal Accounting Officer
Edson Castro, Director
Francois Martelet, President CEO, Director
John Prendergast, Executive Chairman and CEO
Andrew Dahl, Director

Avax Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avax Techs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Avax Techs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avax Techs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avax Techs will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Avax Techs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avax Techs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avax Techs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avax Techs to buy it.
The correlation of Avax Techs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avax Techs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avax Techs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avax Techs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Avax Techs is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Avax Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Avax Techs Stock. Highlighted below are key reports to facilitate an investment decision about Avax Techs Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avax Techs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy Avax Stock please use our How to Invest in Avax Techs guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Avax Stock analysis

When running Avax Techs' price analysis, check to measure Avax Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avax Techs is operating at the current time. Most of Avax Techs' value examination focuses on studying past and present price action to predict the probability of Avax Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avax Techs' price. Additionally, you may evaluate how the addition of Avax Techs to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is Avax Techs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avax Techs. If investors know Avax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avax Techs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
0.001
Quarterly Revenue Growth
3.749
Return On Assets
(4.57)
The market value of Avax Techs is measured differently than its book value, which is the value of Avax that is recorded on the company's balance sheet. Investors also form their own opinion of Avax Techs' value that differs from its market value or its book value, called intrinsic value, which is Avax Techs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avax Techs' market value can be influenced by many factors that don't directly affect Avax Techs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avax Techs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avax Techs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avax Techs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.